Sensitization of Coronary α -Adrenoceptor Vasoconstriction in the Prediabetic Metabolic Syndrome

REFERENCES

• Bache R J, Dai X Z, Herzog C A, Schwartz J S. Effects of nonselective and selective alpha 1-adrenergic blockade on coronary blood flow during exercise. Circ Res 1987; 61: II36–II41, [INFOTRIEVE], [CSA]
   Google Scholar
• Brunner E J, Hemingway H, Walker B R, Page M, Clarke P, Juneja M, Shipley M J, Kumari M, Andrew R, Seckl J R, Papadopoulos A, Checkley S, Rumley A, Lowe G D, Stansfeld S A, Marmot M G. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002; 106: 2659–2665, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chilian W M. Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation. Circulation 1991; 84: 2108–2122, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chilian W M, Layne S M, Eastham C L, Marcus M L. Heterogeneous microvascular coronary alpha-adrenergic vasoconstriction. Circ Res 1989; 64: 376–388, [INFOTRIEVE], [CSA]
   Google Scholar
• Dai X Z, Chen D G, Bache R J. Alpha-adrenergic effects of dopamine and dobutamine on the coronary circulation. J Cardiovasc Pharmacol 1989; 14: 82–87, [INFOTRIEVE], [CSA]
   Google Scholar
• Dodd-o J M, Gwirtz P A. Coronary alpha 1-adrenergic constrictor tone varies with intensity of exercise. Med Sci Sports Exerc 1996; 28: 62–71, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Fagius J. Sympathetic nerve activity in metabolic control—some basic concepts. Acta Physiol Scand 2003; 177: 337–343, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Feigl E O. Neural control of coronary blood flow. J Vasc Res 1998; 35: 85–92, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ford E S, Giles W H, Mokdad A H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444–2449, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Frisbee J C. Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol 2004; 97: 764–772, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gorman M W, Tune J D, Richmond K N, Feigl E O. Feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol 2000; 89: 1892–1902, [INFOTRIEVE], [CSA]
   Google Scholar
• Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba P L, Mancia G. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005; 48: 1359–1365, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Grundy S M, Benjamin I J, Burke G L, Chait A, Eckel R H, Howard B V, Mitch W, Smith S C, Jr, Sowers J R. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134–1146, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Guner S, Arioglu E, Tay A, Tasdelen A, Aslamaci S, Bidasee K R, Dincer U D. Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage. Mol Cell Biochem 2004; 263: 143–150, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gwirtz P A, Dodd-O J M, Downey H F, Mass H J, Barron B A, Williams A G, Jr, Jones C E. Effects of a coronary alpha 1-constriction on transmural left ventricular flow and contractile function. Am J Physiol 1992; 262: H965–H972, [INFOTRIEVE], [CSA]
   Google Scholar
• Henry P, Thomas F, Benetos A, Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension 2002; 40: 458–463, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Heusch G, Deussen A, Schipke J, Thamer V. Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 1984; 6: 961–968, [INFOTRIEVE], [CSA]
   Google Scholar
• Huggett R J, Burns J, Mackintosh A F, Mary D A. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44: 847–852, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Knudson J D, Dincer U D, Dick G M, Shibata H, Akahane R, Saito M, Tune J D. Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H1038–H1046, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kondo I, Mizushige K, Hirao K, Nozaki S, Tsuji T, Masugata H, Kohno M, Matsuo H. Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity. Ultrasound Med Biol 2001; 27: 1199–1205, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lakka H M, Laaksonen D E, Lakka T A, Niskanen L K, Kumpusalo E, Tuomilehto J, Salonen J T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–408, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Molina P E, Williams P, Abumrad N N. Histaminergic contribution to the metabolic effects of neuroglucopenia. Am J Physiol 1997; 272: R1918–R1924, [INFOTRIEVE], [CSA]
   Google Scholar
• Setty S, Sun W, Martinez R, Downey H F, Tune J D. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. J Appl Physiol 2004; 97: 431–438, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Setty S, Sun W, Tune J D. Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol 2003; 98: 416–423, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Stepp D W, Frisbee J C. Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 2002; 282: H816–H820, [INFOTRIEVE], [CSA]
   Google Scholar
• Zhang C, Knudson J D, Setty S, Araiza A, Dincer U D, Kuo L, Tune J D. Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol Heart Circ Physiol 2005; 288: H2154–H2162, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar